Overview
Very long chain acyl-CoA dehydrogenase deficiency, commonly known as VLCAD deficiency or VLCADD, is a rare inherited metabolic disorder. It affects the body's ability to break down certain long-chain fatty acids — a type of fat found in food and stored in the body — and turn them into energy. This process normally happens in the mitochondria, which are the energy-producing parts of cells. When the ACADVL gene is not working properly, the enzyme responsible for this step is missing or not working well enough, causing fatty acids to build up and energy production to fall short, especially during times of fasting, illness, or physical exercise. The condition can affect the heart, muscles, and liver. Symptoms can range from mild to life-threatening and often first appear in infancy or early childhood, though some people are not diagnosed until adulthood. Common problems include low blood sugar (hypoglycemia), muscle pain and weakness, heart problems, and liver enlargement. Newborn screening programs in many countries now detect VLCAD deficiency at birth, which has greatly improved outcomes. Treatment focuses on preventing the body from running out of energy. This means avoiding long periods without eating, following a low-fat diet with medium-chain fat supplements, and managing illness carefully. With proper management, many people with VLCAD deficiency can live healthy, active lives. However, the condition requires lifelong attention and monitoring.
Also known as:
Key symptoms:
Low blood sugar (hypoglycemia), especially when fasting or sickMuscle pain, cramps, or weakness during or after exerciseExtreme tiredness or fatigueHeart muscle disease (cardiomyopathy), especially in infantsAbnormal heart rhythmsEnlarged liver (hepatomegaly)Breakdown of muscle tissue (rhabdomyolysis) triggered by exercise or illnessDark or cola-colored urine after muscle breakdown episodesNausea and vomiting during metabolic crisesIrritability or poor feeding in infantsLiver problems including elevated liver enzymesPeripheral neuropathy (nerve pain or numbness) in some adults
Clinical phenotype terms (40)— hover any for plain English
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Variable
Can begin at different ages, from infancy through adulthood
Treatments
No FDA-approved treatments are currently listed for Very long chain acyl-CoA dehydrogenase deficiency.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Very long chain acyl-CoA dehydrogenase deficiency at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Very long chain acyl-CoA dehydrogenase deficiency.
Community
No community posts yet. Be the first to share your experience with Very long chain acyl-CoA dehydrogenase deficiency.
Start the conversation →Latest news about Very long chain acyl-CoA dehydrogenase deficiency
No recent news articles for Very long chain acyl-CoA dehydrogenase deficiency.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.What are the specific fasting limits for my child's age, and how should we handle illness or surgery?,How much MCT oil should we use, and how do we incorporate it into meals?,Should my child take triheptanoin (Dojolvi), and would they qualify for it?,What are the signs of a metabolic crisis, and when should we go to the emergency room versus manage at home?,Does my child need regular heart monitoring, and how often should we check liver and muscle enzyme levels?,Are there any restrictions on physical activity, and how can we safely support exercise?,Should other family members be tested, and what are the chances of future children being affected?
Common questions about Very long chain acyl-CoA dehydrogenase deficiency
What is Very long chain acyl-CoA dehydrogenase deficiency?
Very long chain acyl-CoA dehydrogenase deficiency, commonly known as VLCAD deficiency or VLCADD, is a rare inherited metabolic disorder. It affects the body's ability to break down certain long-chain fatty acids — a type of fat found in food and stored in the body — and turn them into energy. This process normally happens in the mitochondria, which are the energy-producing parts of cells. When the ACADVL gene is not working properly, the enzyme responsible for this step is missing or not working well enough, causing fatty acids to build up and energy production to fall short, especially during
How is Very long chain acyl-CoA dehydrogenase deficiency inherited?
Very long chain acyl-CoA dehydrogenase deficiency follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
Which specialists treat Very long chain acyl-CoA dehydrogenase deficiency?
21 specialists and care centers treating Very long chain acyl-CoA dehydrogenase deficiency are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.